Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-005165
Filing Date
2025-02-21
Accepted
2025-02-21 18:15:38
Documents
2
Period of Report
2025-02-19

Document Format Files

Seq Description Document Type Size
1 form4-02212025_110233.html 4  
1 form4-02212025_110233.xml 4 4743
2 ex24-02212025_110233.htm EX-24 7005
  Complete submission text file 0001415889-25-005165.txt   13156
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Issuer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address
Correia de Simas Jose Manuel (Reporting) CIK: 0001809748 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38661 | Film No.: 25653571